Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Castañon, E. (Eduardo); Bosch-Barrera, J. (Joaquim); Lopez, I. (Inés); Collado, V. (Víctor); Moreno, M. (Marta); Lopez-Picazo, J.M. (José M.); Arbea-Moreno, L. (Leire); Lozano, M.D. (María Dolores); Gil-Bazo, I. (Ignacio)

Authors:

Castañon, E. (Eduardo)

Bosch-Barrera, J. (Joaquim)

Lopez, I. (Inés)

Collado, V. (Víctor)

Moreno, M. (Marta)

Lopez-Picazo, J.M. (José M.)

Arbea-Moreno, L. (Leire)

Lozano, M.D. (María Dolores)

Gil-Bazo, I. (Ignacio)

Keywords:

Carcinoma, Non-Small-Cell Lung/drug therapy
Combined Modality Therapy
Carcinoma, Non-Small-Cell Lung/genetics

Issue Date:

2013

Publisher:

BioMed Central

ISSN:

1479-5876

Citation:

Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM et al. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med. 2013 Jan 11;11:13.

Abstract

A correlation between Id1 and Id3 protein expression is observed. Id1 and Id3 co-expression seems associated with a poor clinical outcome in patients with locally advanced NSCLC treated with definitive chemoradiotherapy.

URI:

https://hdl.handle.net/10171/35339

Appears in Collections:

DA - CUN - Oncología médica - Artículos de revista

Files in This Item: